IRIS vs redalpine

Vates raises €30M from IRIS and Bpifrance

French virtualization company Vates has raised €30 million in growth funding from IRIS' Growth fund and Bpifrance's Large Venture fund. The investment comes amid shifts in the global virtualization market, driven by licensing changes, rising infrastructure costs, and complex architectures. Vates offers an open-source virtualization platform designed to give organizations control, reduce technological dependency, and ensure interoperability and reversibility. The company has expanded internationally, with customers in 100 countries and North America as its largest market. It also joined Gartner's Magic Quadrant for virtualization in 2026. The funding will accelerate Vates' strategy, focusing on next-generation platform development, international expansion in North America and Europe, and building a partner ecosystem. Open source remains central to Vates' approach.

• Vates raised €30 million from IRIS' Growth fund and Bpifrance's Large Venture fund.
• Vates serves customers in 100 countries, with North America as its largest market.
• Vates joined Gartner's Magic Quadrant for virtualization in 2026.

Swiss VC Redalpine Raises $250 Million for A.I., Robotics and Biotech

Zurich-based venture capital firm Redalpine has closed its eighth early-stage fund, Redalpine Capital VIII (RAC VIII), at $250 million (approximately €225 million), its largest early-stage fund to date. The fund was oversubscribed, attracting both returning and new investors, including Aviva Investors, Flexstone Partners, and German development bank KfW. RAC VIII is 25% larger than its predecessor, which closed at $200 million in 2024, and will invest in 15-20 European startups at seed to Series A stages, with ticket sizes ranging from $1-15 million. Focus areas include AI, robotics, and biotech, with an emphasis on AI for drug discovery. Initial investments include Enact Intelligence, Helical, and Arlequin AI. Redalpine now manages over $1.4 billion in assets and has backed companies such as Mistral, N26, and Proxima Fusion. Managing Partner Sebastian Becker highlighted AI's potential to empower European founders, signaling a return of confidence in the region's ecosystem.

• Redalpine closed its eighth early-stage fund, RAC VIII, at $250 million (≈ €225 million), its largest to date.
• The fund was oversubscribed and is 25% larger than its predecessor, which raised $200 million in 2024.
• RAC VIII will invest in 15-20 European startups at seed to Series A, with checks of $1-15 million, focusing on AI, robotics, and biotech.

Calliora raises $6M for AI hospital billing accuracy

Munich-based startup calliora has raised $6 million (approx. €5.1 million) in a pre-seed round led by Bertelsmann Healthcare Investments (BHI) and Swiss VC redalpine. The company's AI platform helps hospitals find billing errors before invoices are sent to health insurers. This comes as German hospitals face stricter audit quotas from 2027 under the GKV contribution rate stabilization law, where high error rates could lead to 100% of invoices being audited. The platform integrates with existing hospital systems, covering coding, case review, MD audit management, and controlling. According to calliora, the platform is already in regular operation in hospitals across five German states, reducing per-case workload by over half and closing more than 90% of identified gaps before billing. The funds will be used to grow the AI, engineering, and product teams. The startup was founded in 2023 by Frederik Träuble and Jonas Wildberger.

• calliora raised $6 million (€5.1 million) in a pre-seed round led by Bertelsmann Healthcare Investments and redalpine.
• The startup's AI platform detects billing errors in hospitals before invoices are sent to insurers.
• From 2027, German hospitals face higher audit quotas up to 100% under the GKV contribution rate stabilization law.

A market that punishes narrative and rewards fundamentals: our current market view

Redalpine published a new market view article on September 29, 2026, discussing the current market dynamics.